CD274 and lung cancer: Emerging frontiers encompassed genomics, gut microbiome, soluble PD-L1, and immune infiltration patterns, driven by multi-omics integration and artificial intelligence.<h4>Conclusion</h4>This study represents the first bibliometric analysis of biomarkers in lung cancer immunotherapy.